| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 03/22/1994 | US5296589 Dissolving in nonreactive solvent, reacting with hydrogen, palladium chloride, hydrochloric acid in sealed vessel at elevated pressure, removing palladium chloride, neutralizing, separating product |
| 03/22/1994 | US5296489 Immunosuppressive macrocyclic compounds |
| 03/17/1994 | WO1994005687A1 Antiviral pyrimidine nucleosides |
| 03/17/1994 | WO1994005686A1 Anomerisation process |
| 03/17/1994 | WO1994005685A1 Macrocyclic compounds useful in therapy |
| 03/17/1994 | WO1994005684A1 N4-methyl-2'-deoxycytidine 5'-triphosphate and its use in polymerase-catalyzed nucleic acid syntheses |
| 03/17/1994 | WO1994005299A1 Medicinal composition |
| 03/17/1994 | CA2143834A1 Antiviral pyrimidine nucleosides |
| 03/17/1994 | CA2122342A1 Pharmaceutical composition |
| 03/16/1994 | EP0587364A1 A process for anomerizing nucleosides |
| 03/16/1994 | EP0586570A1 Backbone modified oligonucleotide analogues |
| 03/16/1994 | EP0586523A1 Determination of prodrugs metabolizable by the liver and therapeutic use thereof |
| 03/16/1994 | EP0586520A1 Backbone modified oligonucleotide analogs |
| 03/16/1994 | EP0354246B1 5'-Phosphonates of 3'-azido-2',3'-dideoxynucleosides |
| 03/16/1994 | CN1083818A Antiparasitic agents |
| 03/16/1994 | CA2078256A1 Synthesis of sulfide-linked di-or oligonucleotide analogs and incorporation into antisense dna or rna |
| 03/09/1994 | EP0586298A1 Inhibitor of herpes simplex viral thymidine kinase |
| 03/09/1994 | CN1083486A Heteroatoms-containing tricyclic compounds |
| 03/08/1994 | US5292725 Administering particular compounds against various parasites, mycoplasmas, other indications and other infections |
| 03/08/1994 | US5292498 Method of treating lung disease with uridine triphosphates |
| 03/03/1994 | WO1994004548A1 Chemically reversible aptamers |
| 03/03/1994 | WO1994004546A1 Moranoline derivative |
| 03/03/1994 | WO1994004541A2 Protein kinase inhibitors and related compounds combined with taxol |
| 03/03/1994 | WO1994004017A2 New method of treatment |
| 03/03/1994 | CA2140653A1 Protein kinase inhibitors and related compounds combined with taxol |
| 03/03/1994 | CA2104895A1 Inhibitor of herpes simplex viral thymidine kinase |
| 03/02/1994 | EP0584200A1 Trifluoromethyl analogs of fucose and uses thereof |
| 03/01/1994 | US5290927 Process for preparing 2',3'-dideoxyadenosine |
| 03/01/1994 | US5290804 Anthelmintic milbemycin analogs of novel microorganisms |
| 03/01/1994 | US5290772 Immunosuppressant agent |
| 03/01/1994 | US5290689 New cyclic FR-900520 microbial biotransformation agent |
| 03/01/1994 | CA1327358C Fluoro cytidine derivatives |
| 03/01/1994 | CA1327357C Antiviral, antitumor and antifungal compositions and their methods of use |
| 02/23/1994 | CN1082549A Anti-proliferative and anti-infammatory compounds: 5- or 6- deoxy hexose monosaccharides having a saturated nitrogen-containing heterocyclic at the 5- or 6- position bound through the nitrogen atom |
| 02/23/1994 | CN1023858C Pesticide composition containing macrolide compound and its making method |
| 02/22/1994 | US5288710 Stable salts of 4"-deoxy-4"-epi-methylamino avermectin Bla/Blb |
| 02/17/1994 | WO1994003185A1 DISUBSTITUTED AND DEOXY DISUBSTITUTED DERIVATIVES OF α-D-MANNOFURANOSIDES AND β-L-GULOFURANOSIDES HAVING ANTI-INFLAMMATORY AND ANTI-PROLIFERATIVE ACTIVITY |
| 02/17/1994 | WO1994003183A1 Medicinal composition for inhibiting cancer metastasis to liver and medicinal composition for curing hepatoma |
| 02/17/1994 | CA2140762A1 Pharmaceutical compositions for preventing liver metastasis of cancer and pharmaceutical composition for the treatment of liver cancer |
| 02/16/1994 | EP0582690A1 Novel immunosuppressant agent from streptomyces braegensis |
| 02/16/1994 | CN1023804C Novel acetylenic, cyano and allenic aristeromycin/adenosine derivatives |
| 02/16/1994 | CN1023803C Novel alpha-glucosidase inhibitors |
| 02/15/1994 | CA1327003C Pharmacological use of uridine in the treatment of nervous disorders |
| 02/09/1994 | EP0582157A1 Method of purifying nucleoside derivatives |
| 02/09/1994 | EP0582153A1 Method of preparing 4-deoxy-D-mannose |
| 02/09/1994 | EP0581959A1 Use of macrolide compounds for eye diseases |
| 02/09/1994 | EP0581916A1 Anti-proliferative and anti-inflammatory compounds: 5- or 6-deoxy hexose monosaccharides having a saturated nitrogen-containing heterocycle at the 5- or 6-position bound through the nitrogen atom |
| 02/08/1994 | US5284877 Alkyl and alkenyl macrolides having immunosuppressive activity |
| 02/08/1994 | US5284834 Adenosine functionalized congeners as cardiovascular treating agents for animals and methods for using same |
| 02/08/1994 | CA1326849C Treatment of malignant tumors with 8 chloroadenosine 3',5'-cyclic phosphate, and preparation thereof |
| 02/03/1994 | WO1994002624A1 A facile enzymatic synthesis of galactosyl-beta-1,3 glycals |
| 02/03/1994 | WO1994002501A1 Novel 2'-o-alkyl nucleosides and phosphoramidites processes for the preparation and uses thereof |
| 02/03/1994 | WO1994002497A1 Sulfo-derivatives of adenosine |
| 02/03/1994 | DE4224878A1 Amphiphilic nucleoside phosphate analogues |
| 02/03/1994 | DE4224737A1 New cytosine analogues with lipophilic protected amino gps. - for treatment of cancer and virus diseases e.g. AIDS, are more protected against enzymatic des-amination and can be used in higher doses than unprotected cpds. |
| 02/02/1994 | EP0580812A1 Anti-tumor and anti-psoriatic agents |
| 02/01/1994 | US5283331 Viricides |
| 02/01/1994 | US5283327 Synthetic intermediate for 2-alkynyladenosine; storage stability |
| 01/26/1994 | EP0579643A1 Atp analogues |
| 01/25/1994 | US5281701 Process and compounds for RNA synthesis |
| 01/20/1994 | WO1994001540A1 Purified saccharose synthase, process for its production and its use |
| 01/20/1994 | WO1994001445A1 Base-protected nucleotide analogs with protected thiol groups |
| 01/20/1994 | WO1994001444A1 Phosphite-borane compounds, and method of making the same |
| 01/20/1994 | WO1994001443A1 Therapeutic nucleosides |
| 01/20/1994 | WO1994001440A1 Boronated phosphoramidate compounds |
| 01/20/1994 | WO1994001413A1 Boronated compounds |
| 01/20/1994 | WO1994001138A1 Covalent polar lipid-peptide conjugates for biological targeting |
| 01/20/1994 | CA2139132A1 Therapeutic nucleosides |
| 01/19/1994 | CN1023561C Process for preparing aristeromycin/adenosine derivatives |
| 01/18/1994 | US5280015 2-substituted adenosines and 2-substituted adenosine 5'-carboxamides |
| 01/18/1994 | CA1326237C Therapeutic nucleosides |
| 01/12/1994 | EP0578208A1 Process for the preparation of 2-fluoro-9-(2,3,5-tri-O-benzyl-beta-arabinofuranozyl)adenine |
| 01/12/1994 | EP0578112A2 Disaccharide derivatives and processes for the preparation thereof |
| 01/12/1994 | EP0577769A1 Pharmaceutical compositions and methods for preventing skin tumor formation and causing regression of existing tumors |
| 01/12/1994 | EP0577725A1 Targeted drug delivery via mixed phosphate derivatives |
| 01/11/1994 | US5278302 Monophosphates |
| 01/11/1994 | US5278150 Vasodilation |
| 01/11/1994 | US5278043 Ruthenium-lumazine energy transfer systems |
| 01/11/1994 | CA1326017C Ribofuranuronic acid derivatives |
| 01/11/1994 | CA1326016C Microbicides |
| 01/06/1994 | WO1994000467A1 Heteroatomic oligonucleoside linkages |
| 01/06/1994 | CA2138770A1 Heteroatomic oligonucleoside linkages |
| 01/05/1994 | EP0577304A1 Stereoselective anion glycosylation process |
| 01/05/1994 | EP0577303A1 Stereoselective glycosylation process |
| 01/05/1994 | CN1080292A Antivibal compounds |
| 01/05/1994 | CN1080287A Kudzu vine root extract, its preparation and use |
| 01/04/1994 | US5276151 Method of synthesis of 1,3-dioxolane nucleosides |
| 01/04/1994 | US5276143 Dideoxyfructonucleosides and deoxyfructonucleotides |
| 01/04/1994 | US5276033 Miticides, anthelmintics or insecticides to protect plants |
| 01/04/1994 | US5276020 Anti-virals |
| 01/04/1994 | CA2099475A1 Disaccharide derivatives and processes for the preparation thereof |
| 01/04/1994 | CA1325803C Useful compounds in particular for cancer radiotherapy and imagery and new steroid hormone receptors specific ligands |
| 12/29/1993 | EP0576230A1 2'-deoxy-2', 2'-difluoro(4-substituted pyrimidine) nucleosides having antiviral and anti-cancer activity and intermediates |
| 12/29/1993 | EP0576227A2 2'-Deoxy-2',2'-difluoro(2,6,8-substituted) purine nucleosides having anti-viral and anti-cancer activity and intermediates |
| 12/29/1993 | EP0575955A1 Process for producing staurosporine derivatives |
| 12/29/1993 | EP0575482A1 Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane |
| 12/28/1993 | US5274113 Long wavelength chemically reactive dipyrrometheneboron difluoride dyes and conjugates |
| 12/28/1993 | US5273979 Rapamycins; preventing transplant rejection |
| 12/23/1993 | WO1993025566A1 Deuterated nucleosides |
| 12/23/1993 | WO1993025565A1 1,5-anhydrohexitol nucleoside analogues and pharmaceutical use thereof |